MedPath

Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients with a Primary Malignancy of the Central Nervous System

Not Applicable
Not yet recruiting
Conditions
Central Nervous System Cancer
Psychological Distress
Interventions
Other: Teleconsultation for psychological support
Registration Number
NCT06485310
Lead Sponsor
Centre Hospitalier Universitaire de la Réunion
Brief Summary

The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group).

Participants will be randomized into two groups :

* group A) intervention: usual care + nurse teleconsultation for psychological support

* group B) control: usual care alone

Enrolment = Day0 (D0)

Participants will :

* groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire)

* Group A : D0+2/4 das : nursing teleconsultation for psychological support

* Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion

* Group A : D0+15days: semi-directive interview, at home, for voluntary patients.

Detailed Description

The expected benefits are as follows:

For the patient :

* Reduction in pre-treatment psychological distress

* Reduced pre-treatment anxiety and depression

* Better understanding of disease and treatments

* Better adherence to the care proposed in the treatment pathway

* Reduced stress during first hospital treatment

For healthcare professionals :

* Early detection of psychological distress

* Early detection of unmet needs and appropriate individualized responses

* Establishment of a climate of trust between patient and caregiver

* Improved professional practices

For the healthcare system :

* Lower healthcare costs (fewer anxiolytic treatments, etc.)

* Therapy to be integrated into the treatment pathway of patients with central nervous system cancer

* Reduced socio-territorial inequalities in healthcare provision

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
58
Inclusion Criteria
  • aged 18 and over
  • being treated for a primary malignant tumor of the central nervous system (positive biopsy)
  • with a Mini-Mental State score greater than 24
  • not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
  • with a distress score above 3 on the Psychological Distress Thermometer
  • have access to computer equipment equipped with a microphone and webcam (smartphone, computer)
  • able to read, write and speak French
  • have given free and informed consent
  • being affiliated to a social security scheme
Exclusion Criteria
  • with a history of psychiatric illness
  • with recurrent cancer of the cerebral nervous system
  • having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
  • under guardianship, curatorship or deprived of liberty

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TELECONSULTATIONTeleconsultation for psychological supportTeleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice.
Primary Outcome Measures
NameTimeMethod
Distress thermometer10 days

Comparison of the change in psychological distress score, measured using the psychological distress screening tool (from National Comprehensive Cancer Network) between the 2 groups between inclusion (T0) and before the first anti-cancer therapy (T1).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Reunion Island - Neurosurgery department

🇫🇷

St Pierre, Reunion, France

© Copyright 2025. All Rights Reserved by MedPath